Zomedica (ZOM)
(Delayed Data from AMEX)
$0.14 USD
+0.01 (6.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.13 -0.01 (-5.80%) 6:56 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.14 USD
+0.01 (6.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.13 -0.01 (-5.80%) 6:56 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
What's in Store for Zomedica (ZOM)This Earnings Season?
by Zacks Equity Research
Zomedica (ZOM) may provide an update on Truforma commercialization progress when it reports fourth-quarter 2020 results.
Zomedica (ZOM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Zomedica (ZOM) will provide an update on Truforma, its inaugural point-of-care diagnostic biosensor platform, when it reports second-quarter 2020 results
Zomedica Pharmaceuticals Corp. (ZOM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Zomedica Pharmaceuticals Corp. (ZOM) closed the most recent trading day at $0.16, moving +0.57% from the previous trading session.
Zomedica Pharmaceuticals Corp. (ZOM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Zomedica Pharmaceuticals Corp. (ZOM) closed at $0.16 in the latest trading session, marking a -0.3% move from the prior day.
Zomedica Pharmaceuticals Corp. (ZOM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Zomedica Pharmaceuticals Corp. (ZOM) closed at $0.16 in the latest trading session, marking a +1.31% move from the prior day.
Zomedica (ZOM) in Focus: Stock Moves 7.2% Higher
by Zacks Equity Research
Zomedica (ZOM) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Zomedica Pharmaceuticals Corp (ZOM) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Zomedica Pharmaceuticals Corp (ZOM) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Qorvo, Zomedica Tie-Up to Enhance Vet Health with BAW Sensors
by Zacks Equity Research
Qorvo's (QRVO) subsidiary, Qorvo Biotechnologies, inked a deal with Zomedica to improve the veterinary health domain with BAW-based filter technology.